Ponatinib-d8
|
- $220 - $2545
- Product name: Ponatinib-d8
- CAS: 1562993-37-6
- MF: C29H27F3N6O
- MW: 532.57
- EINECS:
- MDL Number:MFCD22380805
- Synonyms:Ponatinib-d8;[2H8]-Ponatinib;AP24534 D8;Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)methyl]-3-(trifluoromethyl)phenyl]-;D8-Ponatinib
13 prices
Selected condition:
Brand
- aablocks
- Arctom
- Cayman Chemical
- ChemScene
- TRC
- Usbiological
Package
- 1mg
- 2.5mg
- 5mg
- 10mg
- Manufactureraablocks
- Product numberAA01LIY6
- Product descriptionPonatinib-d8 ≥99%deuteratedforms(d1-d8)
- Packaging1mg
- Price$390
- Updated2026-05-30
- Buy
- ManufacturerArctom
- Product numberHY-12047S
- Product descriptionPonatinib-d8 99.16%
- Packaging1mg
- Price$323
- Updated2026-05-26
- Buy
- ManufacturerCayman Chemical
- Product number28905
- Product descriptionPonatinib-d8 ≥99%deuteratedforms(d1-d8)
- Packaging1mg
- Price$390
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number28905
- Product descriptionPonatinib-d8
- Packaging1mg
- Price$354
- Updated2024-03-01
- Buy
- ManufacturerChemScene
- Product numberCS-0019838
- Product descriptionPonatinib-d8 99.16%
- Packaging1mg
- Price$368
- Updated2026-06-04
- Buy
- ManufacturerChemScene
- Product numberCS-0019838
- Product descriptionPonatinib-d8 99.16%
- Packaging1mg
- Price$368
- Updated2026-06-04
- Buy
- ManufacturerTRC
- Product numberTRC-P688252-5MG
- Product descriptionPonatinib-d8
- Packaging5mg
- Price$1352
- Updated2026-06-03
- Buy
- ManufacturerTRC
- Product numberTRC-P688252-10MG
- Product descriptionPonatinib-d8
- Packaging10mg
- Price$2545
- Updated2026-06-03
- Buy
- ManufacturerTRC
- Product numberTRC-P688252-1MG
- Product descriptionPonatinib-d8
- Packaging1mg
- Price$300
- Updated2026-06-03
- Buy
- ManufacturerTRC
- Product numberP688252
- Product descriptionPonatinib-d8
- Packaging1mg
- Price$220
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number462817
- Product descriptionPonatinib-d8
- Packaging2.5mg
- Price$941
- Updated2026-06-03
- Buy
- ManufacturerUsbiological
- Product number462817
- Product descriptionPonatinib-d8
- Packaging1mg
- Price$531
- Updated2026-06-03
- Buy
- ManufacturerUsbiological
- Product number462817
- Product descriptionPonatinib-d8
- Packaging1mg
- Price$531
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01LIY6 | Ponatinib-d8 ≥99%deuteratedforms(d1-d8) | 1mg | $390 | 2026-05-30 | Buy |
| Arctom | HY-12047S | Ponatinib-d8 99.16% | 1mg | $323 | 2026-05-26 | Buy |
| Cayman Chemical | 28905 | Ponatinib-d8 ≥99%deuteratedforms(d1-d8) | 1mg | $390 | 2026-04-30 | Buy |
| Cayman Chemical | 28905 | Ponatinib-d8 | 1mg | $354 | 2024-03-01 | Buy |
| ChemScene | CS-0019838 | Ponatinib-d8 99.16% | 1mg | $368 | 2026-06-04 | Buy |
| ChemScene | CS-0019838 | Ponatinib-d8 99.16% | 1mg | $368 | 2026-06-04 | Buy |
| TRC | TRC-P688252-5MG | Ponatinib-d8 | 5mg | $1352 | 2026-06-03 | Buy |
| TRC | TRC-P688252-10MG | Ponatinib-d8 | 10mg | $2545 | 2026-06-03 | Buy |
| TRC | TRC-P688252-1MG | Ponatinib-d8 | 1mg | $300 | 2026-06-03 | Buy |
| TRC | P688252 | Ponatinib-d8 | 1mg | $220 | 2021-12-16 | Buy |
| Usbiological | 462817 | Ponatinib-d8 | 2.5mg | $941 | 2026-06-03 | Buy |
| Usbiological | 462817 | Ponatinib-d8 | 1mg | $531 | 2026-06-03 | Buy |
| Usbiological | 462817 | Ponatinib-d8 | 1mg | $531 | 2021-12-16 | Buy |
Properties
storage temp. :Store at -20°C
solubility :DMSO: soluble; Methanol: soluble
form :A solid
color :White to light yellow
solubility :DMSO: soluble; Methanol: soluble
form :A solid
color :White to light yellow
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
Ponatinib-d8 is an isotope labelled compound of Ponatinib (P688250). Ponatinib is a tyrosine kinase inhibitors (TKI) and used to treat chronic myeloid leukemia (CML) (1,2,3). Ponatinib is also used in combination with other drugs, such as forskolin, to combat TKI resistance in patient with CML (3), targeted drug in small-cell lung cancer. It is a COVID19-related research product.Related product price
-
Ponatinib
$10-1963.5 -
Ibrutinib
$5-1360 -
PIQCTGMSNWUMAF-UFBJYANTSA-N
$155-6378.5
Suppliers and manufacturers
TargetMol Chemicals Inc.
Amadis Chemical Company Limited
Daicel Chiral Technologies (China)CO.,LTD
Artis Biotech Co. Ltd.
Shanghai EFE Biological Technology Co., Ltd.
Chengdu Novel Biomedical Co., Ltd.
Shanghai Hongye Biotechnology Co. Ltd
Shenzhen Polymeri Biochemical Technology Co., Ltd.
ChemeGen(Shanghai) Biotechnology Co.,Ltd.




